CWM
FLNA

CCG Wealth Management’s Filana Therapeutics FLNA Stock Holding History

CCG Wealth Management’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-8,723
Closed -$214K – 68
2023
Q2 		$214K Buy
+8,723
New +$210K 0.13% 58
2023
Q1 		– Sell
-7,366
Closed -$218K – 98
2022
Q4 		$218K Sell
7,366
-2,500
-25% -$89.9K 0.12% 87
2022
Q3 		$413K Buy
+9,866
New +$266K 0.25% 44

Other funds holding FLNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
GCM
Gallacher Capital Management Lone Tree, Colorado $178M AUM 29.29% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

CCG Wealth Management's FLNA Position: Q3 2023 in Review

CCG Wealth Management sold out of Filana Therapeutics (FLNA) in Q3 2023, closing a stake of 8,723 shares — an estimated $214K sold.

CCG Wealth Management first reported a position in FLNA in Q3 2022 and held it in 3 quarters. The position peaked at $413K in Q3 2022. 140 funds tracked by Wall St. Rank hold FLNA as of Q3 2023.

  • CCG Wealth Management reported no remaining Filana Therapeutics position as of Q3 2023 after selling out during the quarter.
  • CCG Wealth Management sold 8,723 Filana Therapeutics shares in Q3 2023, an estimated $214K.
  • CCG Wealth Management first reported a position in Filana Therapeutics in Q3 2022 and held it in 3 quarters.
  • CCG Wealth Management's Filana Therapeutics position peaked at $413K in Q3 2022.
  • 140 funds tracked by Wall St. Rank held Filana Therapeutics as of Q3 2023.

Based on CCG Wealth Management's 13F filing for Q3 2023, filed 10 Oct 2023.